B4GALT5PDACERADMHC-ICD8+ T

Xin Xing1,2, Shi-Qi Yin1, Xia-Qing Li1

  • 1Shanghai Fengxian District Central Hospital, School of Medicine, Anhui University of Science and Technology, Shanghai, China.

概括

β-1,4-Galactosyltransferase-5 (B4GALT5) 通过降低CD8+ T细胞活性,促进胰腺癌免疫逃避. 针对B4GALT5提供了一个有希望的策略,以改善胰腺管腺癌患者的治疗结果.